4 withdrawn. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Withdrawn 4 |
Follow Trachoma: new trials by email Literature Review of Trachoma trials Research Report on Trachoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trachoma Elimination Study by Focused Antibiotic (TESFA) Azithromycin mass treatment, Azithromycin targeted treatment - Trachoma | Phase 4 | Withdrawn | Emory University | 2025-06-01 | 2025-07-16 | |
| Azithromycin Reduction to Reach Elimination of Trachoma B Azithromycin - Trachoma | Phase 4 | Withdrawn | University of California, San Francisco | 2024-10-01 | 2026-03-13 | |
| Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis azithromycin, ivermectin, albendazole - Trachoma, Lymphatic Filariasis | Phase 4 | Withdrawn | Emory University | 2014-02-01 | 2014-05-22 | |
| Azithromycin in Control of Trachoma II Azithromycin - Trachoma | Phase 4 | Withdrawn | University of California, San Francisco | 2005-06-01 | 2012-04-16 |
Communicable Diseases (1) · Elephantiasis, Filarial (1) · Neglected Diseases (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Chlamydia Infections (4) · Chlamydiaceae Infections (4) · Conjunctival Diseases (4) · Conjunctivitis (4) · Conjunctivitis, Bacterial (4) · Corneal Diseases (4) · Eye Diseases (4) · Eye Infections (4) · Eye Infections, Bacterial (4) · Gram-Negative Bacterial Infections (4) · Infections (4) · Disease Attributes (2) · Pathologic Processes (2)
Azithromycin (4) · Albendazole (1) · Ivermectin (1)
Emory University (2) · University of California, San Francisco (2)
Democratic Republic of the Congo (1) · Mozambique (1) · United States (1)
Catherine Oldenburg, ScD, MPH (1) · Chandler R Dawson, MD (1) · Elodie Lebas, RN (1) · Huub C Gelderblom, MD, PhD, MPH (1) · Julius Schachter, PhD (1) · Kelly Callahan, MPH (1) · Ricardo Thompson, PhD (1) · Thomas Lietman, MD (1)
5UG1EY030833 (1), R01AI048789 (1)